发明名称 PYRIMIDINE COMPOUND
摘要 <p>Disclosed is a pyrimidine derivative with excellent MLR inhibitory effect or a pharmacologically acceptable salt thereof. Specifically, disclosed is a pyrimidine derivative represented by the general formula (I) below or a pharmacologically acceptable salt thereof. (I) (In the formula, R&lt;1&gt; represents a lower alkyl group; R&lt;2&gt; represents an aryl group or the like; A represents -NH- or the like; R&lt;3&gt; represents -NHR&lt;6&gt; group (wherein R&lt;6&gt; represents an aryl group or the like) or the like; R&lt;4&gt; represents a hydrogen atom or the like; and R&lt;5&gt; represents a heterocyclic group or the like.)</p>
申请公布号 WO2005037801(A1) 申请公布日期 2005.04.28
申请号 WO2004JP15955 申请日期 2004.10.21
申请人 SANKYO COMPANY, LIMITED;TSURUOKA, HIROYUKI;MATSUDA, AKIHISA;SUGANO, YUICHI;TATSUTA, TORU 发明人 TSURUOKA, HIROYUKI;MATSUDA, AKIHISA;SUGANO, YUICHI;TATSUTA, TORU
分类号 C07D401/12;(IPC1-7):C07D239/48;A61P1/16;A61P1/04;A61K31/506;A61K31/505;C07D413/12;C07D409/14;C07D409/12;C07D405/12;C07D405/04;C07D403/14;C07D403/12;C07D403/04;C07D401/14;C07D401/04;C07D239/42;A61P43/00;A61P37/08;A61P37/06;A61P35/00;A61P29/00;A61P27/16;A61P25/28;A61P21/04;A61P17/06;A61P17/00;A61P13/12;A61P11/06;A61P7/06;A61P5/14;A61P3/10 主分类号 C07D401/12
代理机构 代理人
主权项
地址